(Q41920666)

English

Patients with systemic lupus erythematosus and secondary antiphospholipid syndrome have decreased numbers of circulating CD4⁺CD25⁺Foxp3⁺ Treg and CD3⁻CD19⁺ B cells

scientific article published on May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Patients with systemic lupus erythematosus and secondary antiphospholipid syndrome have decreased numbers of circulating CD4⁺CD25⁺Foxp3⁺ Treg and CD3⁻CD19⁺ B cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

secondary antiphospholipid syndrome

1 reference

based on heuristic

inferred from title

antiphospholipid syndrome

1 reference

based on heuristic

inferred from title

author name string

Ester Rosári Raphaelli Dal Ben

1

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Carine Hartmann do Prado

2

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Talita Siara Almeida Baptista

3

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Moisés Evandro Bauer

4

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Henrique Luiz Staub

5

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

publication date

1 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Revista Brasileira de reumatologia

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

241-246

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Links between type I interferons and the genetic basis of disease in mouse lupus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

Thrombosis in systemic lupus erythematosus: risk and protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new.

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

CD4+CD25highFoxP3+ regulatory T-cells in hematologic diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

Decrease of regulatory T cells in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a link to autoimmunity?

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

How regulatory T cells work

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

Decreased levels of circulating CD4+CD25+Foxp3+ regulatory T cells in patients with primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

The plasticity and stability of regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

Autologous regulatory T cells for the treatment of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FJ.RBR.2013.09.001

21 January 2018

Identifiers

10.1016/J.RBR.2013.09.001

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41920666&oldid=2204857997"